2016 annual financial data
Summit Therapeutics 2016 Operating margin
Summit Therapeutics 2016 operating margin with verified reported values.
Direct answer
Operating margin was -1,046%.
Operating income was -24,853,000 GBP and net income was -21,371,000 GBP.
Operating cash flow was 15,175,680 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,376,000 GBP
- Operating income
- -24,853,000 GBP
- Net income
- -21,371,000 GBP
- Operating cash flow
- 15,175,680 GBP